323 related articles for article (PubMed ID: 27561302)
1. B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
Thomas PJ; Xu R; Martin PT
Am J Pathol; 2016 Sep; 186(9):2429-48. PubMed ID: 27561302
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Xu R; DeVries S; Camboni M; Martin PT
Am J Pathol; 2009 Jul; 175(1):235-47. PubMed ID: 19498002
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
[TBL] [Abstract][Full Text] [Related]
4. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates.
Chicoine LG; Rodino-Klapac LR; Shao G; Xu R; Bremer WG; Camboni M; Golden B; Montgomery CL; Shontz K; Heller KN; Griffin DA; Lewis S; Coley BD; Walker CM; Clark KR; Sahenk Z; Mendell JR; Martin PT
Mol Ther; 2014 Apr; 22(4):713-24. PubMed ID: 24145553
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
[TBL] [Abstract][Full Text] [Related]
6. Skeletal, cardiac, and respiratory muscle function and histopathology in the P448Lneo- mouse model of FKRP-deficient muscular dystrophy.
Yu Q; Morales M; Li N; Fritz AG; Ruobing R; Blaeser A; Francois E; Lu QL; Nagaraju K; Spurney CF
Skelet Muscle; 2018 Apr; 8(1):13. PubMed ID: 29625576
[TBL] [Abstract][Full Text] [Related]
7. rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.
Xu R; Jia Y; Zygmunt DA; Martin PT
Mol Ther; 2019 Mar; 27(3):636-649. PubMed ID: 30711447
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A.
Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT
Am J Pathol; 2007 Jul; 171(1):181-99. PubMed ID: 17591965
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.
Xu L; Lu PJ; Wang CH; Keramaris E; Qiao C; Xiao B; Blake DJ; Xiao X; Lu QL
Mol Ther; 2013 Oct; 21(10):1832-40. PubMed ID: 23817215
[TBL] [Abstract][Full Text] [Related]
10. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
[TBL] [Abstract][Full Text] [Related]
11. Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i.
Maricelli JW; Kagel DR; Bishaw YM; Nelson OL; Lin DC; Rodgers BD
J Appl Physiol (1985); 2017 Nov; 123(5):1126-1138. PubMed ID: 28663375
[TBL] [Abstract][Full Text] [Related]
12. Adeno-Associated Virus-Mediated Mini-Agrin Delivery Is Unable to Rescue Disease Phenotype in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2I.
Vannoy CH; Zhou H; Qiao C; Xiao X; Bang AG; Lu QL
Am J Pathol; 2017 Feb; 187(2):431-440. PubMed ID: 28107841
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation.
Wu B; Shah SN; Lu P; Richardson SM; Bollinger LE; Blaeser A; Madden KL; Sun Y; Luckie TM; Cox MD; Sparks S; Harper AD; Lu QL
Am J Pathol; 2016 Jun; 186(6):1635-48. PubMed ID: 27109613
[TBL] [Abstract][Full Text] [Related]
14. Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.
Qiao C; Wang CH; Zhao C; Lu P; Awano H; Xiao B; Li J; Yuan Z; Dai Y; Martin CB; Li J; Lu Q; Xiao X
Mol Ther; 2014 Nov; 22(11):1890-9. PubMed ID: 25048216
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C476-88. PubMed ID: 19109526
[TBL] [Abstract][Full Text] [Related]
16. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
[TBL] [Abstract][Full Text] [Related]
17. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
18. A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.
Serafini PR; Feyder MJ; Hightower RM; Garcia-Perez D; Vieira NM; Lek A; Gibbs DE; Moukha-Chafiq O; Augelli-Szafran CE; Kawahara G; Widrick JJ; Kunkel LM; Alexander MS
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232282
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
[TBL] [Abstract][Full Text] [Related]
20. Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I.
Azzag K; Ortiz-Cordero C; Oliveira NAJ; Magli A; Selvaraj S; Tungtur S; Upchurch W; Iaizzo PA; Lu QL; Perlingeiro RCR
Skelet Muscle; 2020 Apr; 10(1):10. PubMed ID: 32321586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
